| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |